Pharmaceutical and Medical Devices
Clayton Utz is the legal firm of choice for many Australian and global pharma and medical device companies. Our team has a unique combination of scientific, regulatory and legal expertise in relation to prescription pharmaceuticals, OTC and complementary medicines and medical devices which means we are able to understand and respond swiftly to our clients' needs.
We advise our clients about all aspects of the product lifecycle, including the protection of IP, clinical trials, marketing approval, product labelling and other regulatory obligations, reimbursement, administrative law remedies, promotion and distribution, product risk, product liability and product recall.
Retirement Villages and Aged Care
With the demographic changes affecting Australia, the retirement village and aged care sectors are becoming increasingly important and they require advisers with an in-depth knowledge of the legislation and policy that govern this area. Clayton Utz' expertise extends beyond the relevant Commonwealth- and State-based legislation to the numerous regulations, principles, and policy documents which are fundamental to the industry. Our expertise covers both commercial and regulatory issues and mergers and acquisitions.
We provide advice to local, State and Federal government in the area of health, including the interaction between State and Territory legislation and relevant Commonwealth legislation. Our partners have government experience specific to the healthcare industry, such as the drafting of health portfolio legislation including private health insurance (including private health insurance), pharmaceutical benefits and aged care.
Health and Private Health Insurance
Clayton Utz has extensive experience in the full range of services required in the health and health insurance industry. For example, we've advised extensively on compliance issues, commercial agreements, mergers and acquisitions, privacy and governance issues.
Biotechnology companies require advice in relation to a broad range of issues such as commercialisation, intellectual property, mergers and acquisitions, regulatory compliance, fund raising and product related issues. Clayton Utz understands the legal, commercial and regulatory frameworks relevant to the business of biotechnology.
Pathology and Diagnostic Imaging
Clayton Utz has extensive experience in advising on the full range of matters relevant to the pathology and diagnostic imaging sectors including leasing, privacy, compliance with the anti-kickback provisions of the Health Insurance Act, service agreements, mergers and acquisitions and structuring.